Status: current, Primitive. Date: 30-Jun 2014. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 61081000168111 | Tazocin EF 4 g/500 mg (trade product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 61091000168114 | Tazocin EF 4 g/500 mg | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tazocin EF 4 g/500 mg | Is a | trade product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Tazocin EF 4 g/500 mg powder for injection, 4.5 g vial | Is a | True | Tazocin EF 4 g/500 mg | Inferred relationship | Some | |
| Tazocin EF 4 g/500 mg powder for injection, 4.5 g vial | has TP | True | Tazocin EF 4 g/500 mg | Inferred relationship | Some | |
| Tazocin EF 4 g/500 mg (piperacillin 4 g + tazobactam 500 mg) powder for injection, 1 x 4.5 g vial (containered trade product pack) | has TP | True | Tazocin EF 4 g/500 mg | Inferred relationship | Some |
Reference Sets
FHIR